0001654954-17-005235.txt : 20170531
0001654954-17-005235.hdr.sgml : 20170531
20170531172857
ACCESSION NUMBER: 0001654954-17-005235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170530
FILED AS OF DATE: 20170531
DATE AS OF CHANGE: 20170531
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Latkin Jed
CENTRAL INDEX KEY: 0001554593
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 17882448
MAIL ADDRESS:
STREET 1: 152 W. 57TH STREET
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
4
1
section16.xml
FORM 4 LATKIN
X0306
4
2017-05-30
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001554593
Latkin Jed
4995 BRADENTON AVE
SUITE 240
DUBLIN
OH
43017
false
true
false
COO and CFO
Common Stock, $.001 par value
2017-05-30
4
P
false
7600
.4364
A
50159
D
/s/ Jed A. Latkin
2017-05-31